Typically prescribed oral antibiotic prophylaxis — Competitive Intelligence Brief

Typically prescribed oral antibiotic prophylaxis (Typically prescribed oral antibiotic prophylaxis) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antibiotic (class varies by specific agent). Area: Infectious Disease.

marketed Antibiotic (class varies by specific agent) Infectious Disease Small molecule

Target snapshot

Typically prescribed oral antibiotic prophylaxis (Typically prescribed oral antibiotic prophylaxis) — Women and Infants Hospital of Rhode Island. Oral antibiotics prevent bacterial infection by inhibiting bacterial protein synthesis or cell wall formation.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Typically prescribed oral antibiotic prophylaxis TARGET	Typically prescribed oral antibiotic prophylaxis	Women and Infants Hospital of Rhode Island	marketed	Antibiotic (class varies by specific agent)
Antibiotic administration	Antibiotic administration	University of California, San Diego	phase 3	Antibiotic (class varies by specific agent)
Standard antibiotic prophylaxis	Standard antibiotic prophylaxis	Western Galilee Hospital-Nahariya	phase 3	Antibiotic (class varies by specific agent)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antibiotic (class varies by specific agent) class)

1. University of California, San Diego · 1 drug in this class
2. Western Galilee Hospital-Nahariya · 1 drug in this class
3. Women and Infants Hospital of Rhode Island · 1 drug in this class